Keyword Connections

cystic fibrosis

Journals

33

1 Scientific reports

2 PloS one

3 eLife

4 Medicine

5 ACS omega

6 Physical Therapy

7 Free radical biology & medicine

8 molecular microbiology

9 scientific data

10 oncotarget

11 canadian medical education journal

12 new biotechnology

13 bmj open respiratory research

14 jbi database of systematic reviews and implementation reports

15 pediatric pulmonology

16 african health sciences

17 Journal of pain and symptom management

18 Clinical nutrition (Edinburgh, Scotland)

19 health (london, england : 1997)

20 surgery

21 journal of biological methods

22 Journal of the Royal Society, Interface

23 BMC pulmonary medicine

24 clinical nutrition espen

25 clinical medicine & research

26 seminars in cardiothoracic and vascular anesthesia

27 Thorax

28 The Turkish journal of pediatrics

29 virology journal

30 journal of cystic fibrosis : official journal of the european cystic fibrosis society

31 science (new york, ny)

32 cell stem cell

33 epidemiology (sunnyvale, calif)

Research Groups

0

No Research Group Connected

Bibliographies

174

1 Pathways, practices and architectures: Containing antimicrobial resistance in the cystic fibrosis clinic.

2 A Novel Tool to Evaluate the Accuracy of Predicting Survival and Guiding Lung Transplantation in Cystic Fibrosis.

3 High-Efficiency, Selection-free Gene Repair in Airway Stem Cells from Cystic Fibrosis Patients Rescues CFTR Function in Differentiated Epithelia.

4 Cystic fibrosis in Tunisian children: a review of 32 children.

5 Venous thromboembolic events during warm autoimmune hemolytic anemia.

6 Current infection control practices used in Australian and New Zealand cystic fibrosis centers.

7 Interspecies interactions induce exploratory motility in .

8 Respect the poster.

9 New insights into the mycobacterial PE and PPE proteins provide a framework for future research.

10 Utility and validity of dynamic chest radiography in cystic fibrosis (dynamic CF): an observational, non-controlled, non-randomised, single-centre, prospective study.

11 Intention to control low central venous pressure reduced blood loss during laparoscopic hepatectomy: A double-blind randomized clinical trial.

12 Development and Validation of the AdT-Physio Scale: A Tool to Assess Adherence and Perception of Physical Therapist Intervention in Patients With Cystic Fibrosis.

13 Activated L-Arginine/Nitric Oxide Pathway in Pediatric Cystic Fibrosis and Its Association with Pancreatic Insufficiency, Liver Involvement and Nourishment: An Overview and New Results

14 cftr mutation analysis of a caucasian father with congenital bilateral absence of vas deferens, a taiwanese mother, and twins resulting from icsi procedure

15 liver cirrhosis and portal hypertension in cystic fibrosis

16 bronchial epithelial cells from cystic fibrosis patients express a specific long non-coding rna signature upon pseudomonas aeruginosa infection

17 draft genome sequence of acinetobacter pittii st643 shared by cystic fibrosis patients

18 animals devoid of pulmonary system as infection models in the study of lung bacterial pathogens

19 methicillin-resistant staphylococcus aureus in cystic fibrosis patients: do we need to care? a cohort study

20 lying in wait: modeling the control of bacterial infections via antibiotic-induced proviruses

21 perfil nutricional, clínico e socioeconômico de pacientes com fibrose cística atendidos em um centro de referência no nordeste do brasil nutritional, clinical and socioeconomic profile of patients with cystic fibrosis treated at a referral center in northeastern brazil

22 ivs8 polyt and m470v polymorphisms in healthy individuals and cystic fibrosis patients in mazandaran province, iran

23 hyponatremic hypochloremic dehydration in children with cystic fibrosis in slovenia; the incidence and recommendations for prevention and treatment

24 o que é ser mãe de uma criança com fibrose cística qué significa ser madre de un niño con fibrosis quística what is being a mother of a child with cystic fibrosis

25 non-antimicrobial airway management of non-cystic fibrosis bronchiectasis

26 β-sitosterol reduces the expression of chemotactic cytokine genes in cystic fibrosis bronchial epithelial cells

27 densidade mineral óssea, função pulmonar, idade cronológica e idade de diagnóstico em crianças e adolescentes com fibrose cística bone mineral density, pulmonary function, chronological age, and age at diagnosis in children and adolescents with cystic fibrosis

28 chronic cough with normal sweat chloride: phenotypic descriptions of two rare cystic fibrosis genotypes

29 deve-se extrapolar o tratamento de bronquiectasias em pacientes com fibrose cística para aqueles com bronquiectasias de outras etiologias? should the bronchiectasis treatment given to cystic fibrosis patients be extrapolated to those with bronchiectasis from other causes?

30 respiratory muscle strength and exercise performance in cystic fibrosis–a cross sectional study

31 stenotrophomonas maltophilia phenotypic and genotypic diversity during a 10-year colonization in the lungs of a cystic fibrosis patient

32 peritonitis meconial y fibrosis quística meconium peritonitis and cystic fibrosis

33 evolution of stenotrophomonas maltophilia in cystic fibrosis lung over chronic infection: a genomic and phenotypic population study

34 interactions between neutrophils and pseudomonas aeruginosa in cystic fibrosis

35 acute appendicitis mimicking intestinal obstruction in a patient with cystic fibrosis

36 patient’s perception of the meaning of life in cystic fibrosis – its evaluation with respect to the stage of the disease and treatment

37 tobramycin and amikacin delay adhesion and microcolony formation in pseudomonas aeruginosa cystic fibrosis isolates

38 nets and cf lung disease: current status and future prospects

39 sweat conductivity and coulometric quantitative test in neonatal cystic fibrosis screening

40 a vsv-g pseudotyped last generation lentiviral vector mediates high level and persistent gene transfer in models of airway epithelium in vitro and in vivo

41 Evaluation of clinically relevant changes in the lung clearance index in children with cystic fibrosis and healthy controls.

42 Cystic fibrosis related bone disease in children: Can it be predicted?

43 The predictive role of lung clearance index on FEV decline in cystic fibrosis.

44 Genotypic characterization of Pseudomonas aeruginosa isolates from Turkish children with cystic fibrosis

45 Peptide dendrimers as “lead compounds” for the treatment of chronic lung infections by Pseudomonas aeruginosa in cystic fibrosis patients: in vitro and in vivo studies

46 Multidrug-resistant Pseudomonas aeruginosa from sputum of patients with cystic fibrosis demonstrates a high rate of susceptibility to ceftazidime–avibactam

47 Impact of concomitant nontuberculous mycobacteria and Pseudomonas aeruginosa isolates in non-cystic fibrosis bronchiectasis

48 Emergence and spread of worldwide Staphylococcus aureus clones among cystic fibrosis patients

49 Aspergillus fumigatus in the cystic fibrosis lung: pros and cons of azole therapy

50 Role of small colony variants in persistence of Pseudomonas aeruginosa infections in cystic fibrosis lungs

51 Discrepancy in MALDI-TOF MS identification of uncommon Gram-negative bacteria from lower respiratory secretions in patients with cystic fibrosis

52 Genetic relatedness and host specificity of Pseudomonas aeruginosa isolates from cystic fibrosis and non-cystic fibrosis patients

53 Management of refractory Pseudomonas aeruginosa infection in cystic fibrosis

54 Clinical perspective on aztreonam lysine for inhalation in patients with cystic fibrosis

55 Genotypic characterization of Pseudomonas aeruginosa isolates from Turkish children with cystic fibrosis

56 Peptide dendrimers as “lead compounds” for the treatment of chronic lung infections by Pseudomonas aeruginosa in cystic fibrosis patients: in vitro and in vivo studies

57 Multidrug-resistant Pseudomonas aeruginosa from sputum of patients with cystic fibrosis demonstrates a high rate of susceptibility to ceftazidime–avibactam

58 Impact of concomitant nontuberculous mycobacteria and Pseudomonas aeruginosa isolates in non-cystic fibrosis bronchiectasis

59 Emergence and spread of worldwide Staphylococcus aureus clones among cystic fibrosis patients

60 Aspergillus fumigatus in the cystic fibrosis lung: pros and cons of azole therapy

61 Role of small colony variants in persistence of Pseudomonas aeruginosa infections in cystic fibrosis lungs

62 Discrepancy in MALDI-TOF MS identification of uncommon Gram-negative bacteria from lower respiratory secretions in patients with cystic fibrosis

63 Genetic relatedness and host specificity of Pseudomonas aeruginosa isolates from cystic fibrosis and non-cystic fibrosis patients

64 Management of refractory Pseudomonas aeruginosa infection in cystic fibrosis

65 Clinical perspective on aztreonam lysine for inhalation in patients with cystic fibrosis

66 Singing as an adjunct therapy for children and adults with cystic fibrosis.

67 Opportunities to Improve Utilization of Palliative Care among Adults with Cystic Fibrosis: A Systematic Review.

68 SETTING UP OF A HOMECARE SYSTEM FOR HIGH COST NEBULISERS IN A PAEDIATRIC CYSTIC FIBROSIS CENTRE.

69 Psychological predictors of nutritional adherence in adolescents with cystic fibrosis.

70 Loss of incretin effect contributes to postprandial hyperglycaemia in cystic fibrosis-related diabetes.

71 New insights into the immunoproteome of B. cenocepacia J2315 using serum samples from cystic fibrosis patients.

72 Impact of clonally-related Burkholderia contaminans strains in two patients attending an Italian cystic fibrosis centre: a case report.

73 GH-IGF1 Axis in Children with Cystic Fibrosis.

74 Cystic Fibrosis Transmembrane Conductance Regulator: A Possible New Target for Photodynamic Therapy Enhances Wound Healing.

75 Effect of Lumacaftor/Ivacaftor on Pulmonary Exacerbation Rates in Members with Cystic Fibrosis in a Medicaid Population.

76 Major depression and psychiatric comorbidity in Turkish children and adolescents with cystic fibrosis.

77 Thickness of the airway surface liquid layer in the lung is affected in cystic fibrosis by compromised synergistic regulation of the ENaC ion channel.

78 Specific Inhibition of the NLRP3 Inflammasome as an Anti-Inflammatory Strategy in Cystic Fibrosis.

79 Allele specific repair of splicing mutations in cystic fibrosis through AsCas12a genome editing

80 Inspiration for the Future: The Role of Inspiratory Muscle Training in Cystic Fibrosis

81 Genetically diverse Pseudomonas aeruginosa populations display similar transcriptomic profiles in a cystic fibrosis explanted lung

82 Patient-derived pancreas-on-a-chip to model cystic fibrosis-related disorders

83 HDAC6 depletion improves cystic fibrosis mouse airway responses to bacterial challenge

84 A Systematic Review of the Clinical Efficacy and Safety of CFTR Modulators in Cystic Fibrosis

85 A longitudinal characterization of the Non-Cystic Fibrosis Bronchiectasis airway microbiome

86 Anaerobiosis influences virulence properties of Pseudomonas aeruginosa cystic fibrosis isolates and the interaction with Staphylococcus aureus

87 Blocking RpoN reduces virulence of Pseudomonas aeruginosa isolated from cystic fibrosis patients and increases antibiotic sensitivity in a laboratory strain

88 Airway surface liquid acidification initiates host defense abnormalities in Cystic Fibrosis

89 Phenotyping ciliary dynamics and coordination in response to CFTR-modulators in Cystic Fibrosis respiratory epithelial cells

90 Longitudinal development of the airway microbiota in infants with cystic fibrosis

91 Glucose tolerance in Canadian and French cystic fibrosis adult patients

92 Changes in microbiome diversity following beta-lactam antibiotic treatment are associated with therapeutic versus subtherapeutic antibiotic exposure in cystic fibrosis

93 Phage therapy against Pseudomonas aeruginosa infections in a cystic fibrosis zebrafish model

94 Nebulized hypertonic saline triggers nervous system-mediated active liquid secretion in cystic fibrosis swine trachea

95 Microbiome networks and change-point analysis reveal key community changes associated with cystic fibrosis pulmonary exacerbations

96 A paper-based length of stain analytical device for naked eye (readout-free) detection of cystic fibrosis

97 Ursodeoxycholic acid inhibits ENaC and Na/K pump activity to restore airway surface liquid height in cystic fibrosis bronchial epithelial cells

98 Furocoumarins as multi-target agents in the treatment of cystic fibrosis

99 First clinical trials of novel ENaC targeting therapy, SPX-101, in healthy volunteers and adults with cystic fibrosis

100 Liver Ultrasound Patterns in Children with Cystic Fibrosis Correlate with Noninvasive Tests of Liver Disease

101 Lactation Consultation Sustains Breast Milk Intake in Infants with Cystic Fibrosis